Novocure (NVCR) Tops Q3 EPS by 5c

Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.28), $0.05 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $155.1 million versus the consensus estimate of $143.84 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• A. O. Smith CEO Stephen Shafer named chairman
• Meta pauses an AI training program that tracks employees' keystrokes after a companywide leak - Insider